Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
---|---|---|---|---|---|---|---|---|
CAI | CARIS LIFE SCIENCES INC | 2.01% | 3,034,858 | $81,091,406 | 3,034,858 | New | $26.72 | 13F |
ROIV | ROIVANT SCIENCES LTD | 0.77% | 2,779,427 | $31,324,142 | 2,779,427 | New | $11.27 | 13F |
CTMX | CYTOMX THERAPEUTICS INC | 0.47% | 8,461,500 | $19,207,605 | 8,461,500 | New | $2.27 | 13F |
UNH | UNITEDHEALTH GROUP INC (Call) | 0.39% | 50,000 | $15,598,500 | 50,000 | New | $311.97 | 13F |
RAPT | RAPT THERAPEUTICS INC | 0.32% | 1,641,906 | $13,135,248 | 1,641,906 | New | $8 | 13F |
MLYS | MINERALYS THERAPEUTICS INC | 0.25% | 760,351 | $10,287,549 | 760,351 | New | $13.53 | 13F |
CPRX | CATALYST PHARMACEUTICALS INC | 0.22% | 416,900 | $9,046,730 | 416,900 | New | $21.7 | 13F |
ZLAB | ZAI LAB LTD | 0.20% | 231,000 | $8,078,070 | 231,000 | New | $34.97 | 13F |
AZN | ASTRAZENECA PLC (Call) | 0.17% | 100,000 | $6,988,000 | 100,000 | New | $69.88 | 13F |
ITOS | ITEOS THERAPEUTICS INC | 0.17% | 700,000 | $6,979,000 | 700,000 | New | $9.97 | 13F |
URGN | UROGEN PHARMA LTD | 0.16% | 478,400 | $6,554,080 | 478,400 | New | $13.7 | 13F |
ASND | ASCENDIS PHARMA A/S | 0.15% | 34,400 | $5,937,440 | 34,400 | New | $172.6 | 13F |
ALMS | ALUMIS INC | 0.14% | 1,926,423 | $5,779,269 | 1,926,423 | New | $3 | 13F |
JBIO | JADE BIOSCIENCES INC | 0.13% | 531,163 | $5,306,318 | 531,163 | New | $9.99 | 13F |
STTK | Shattuck Labs, Inc. | 0.11% | 5,255,106 | $4,571,942 | 5,255,106 | New | Form 4 | |
CGON | CG ONCOLOGY INC (Call) | 0.10% | 150,000 | $3,900,000 | 150,000 | New | $26 | 13F |
MURA | MURAL ONCOLOGY PUB LTD CO | 0.04% | 588,800 | $1,454,336 | 588,800 | New | $2.47 | 13F |
APLS | APELLIS PHARMACEUTICALS INC (Call) | 0.02% | 50,000 | $865,500 | 50,000 | New | $17.31 | 13F |
LYEL | LYELL IMMUNOPHARMA INC | 0.01% | 51,727 | $457,267 | 51,727 | New | $8.84 | 13F |
INMB | INMUNE BIO INC (Put) | 0.00286% | 50,000 | $115,500 | 50,000 | New | $2.31 | 13F |